<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Sharpe | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/harpcan1/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/harpcan1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Sharpe.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">d2f53442201c156cfdcbbb575f68acfd</guid>
				<title>Sharpe posted an update: Cypripedium japonicum is known to be the indigenous plant to [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39900/</link>
				<pubDate>Thu, 06 Feb 2025 10:53:13 -0800</pubDate>

									<content:encoded><![CDATA[<p>Cypripedium japonicum is known to be the indigenous plant to Korea, Japan, and China. However, C. japonicum represents the most critically endangered plant species in South Korea. The plant is esthetically pleasing due to its flower, which is larger than any other orchidaceous species. Disease symptoms relating to gray mold were observed on C.&hellip;<span class="activity-read-more" id="activity-read-more-39900"><a href="http://www.nationalboardinstitute.com/activity/p/39900/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">66ebe20a08313e4c98b023fcfb3fad95</guid>
				<title>Sharpe posted an update: Hexanitrohexaazaisowurtzitane (CL-20) is a compound with a [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36483/</link>
				<pubDate>Sun, 02 Feb 2025 10:41:32 -0800</pubDate>

									<content:encoded><![CDATA[<p>Hexanitrohexaazaisowurtzitane (CL-20) is a compound with a polycyclic cage and an N-nitro group that has been shown to play an unfavorable role in environmental fate, biosafety, and physical health. The aim of this study was to isolate the microbial community and to identify a single microbial strain that can degrade CL-20 with desirable&hellip;<span class="activity-read-more" id="activity-read-more-36483"><a href="http://www.nationalboardinstitute.com/activity/p/36483/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5ace06933483622f55d994e607189936</guid>
				<title>Sharpe posted an update: Competitive employment could make a substantial contribution [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33688/</link>
				<pubDate>Thu, 30 Jan 2025 10:14:46 -0800</pubDate>

									<content:encoded><![CDATA[<p>Competitive employment could make a substantial contribution to the sense of belonging to society and quality of life of people with intellectual disabilities. Nevertheless, they must cope with stigma-related obstacles and feelings of being dependent on others in the work environment.</p>
<p> Anger is an important clinical feature of posttraumatic&hellip;<span class="activity-read-more" id="activity-read-more-33688"><a href="http://www.nationalboardinstitute.com/activity/p/33688/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">997bbc362ca94148c2479a7a09b18754</guid>
				<title>Sharpe posted an update: To assess endothelial cell loss (ECL) rate and collect [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33110/</link>
				<pubDate>Thu, 30 Jan 2025 06:20:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>To assess endothelial cell loss (ECL) rate and collect safety data in patients with AcrySof L-series Cachet phakic intraocular lens (pIOL) up to 10 years post-implantation.</p>
<p> Clinical settings in the United States, European Union, and Canada.</p>
<p> Nonrandomized, observational, open-label safety study.</p>
<p> Central and peripheral&hellip;<span class="activity-read-more" id="activity-read-more-33110"><a href="http://www.nationalboardinstitute.com/activity/p/33110/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">608abc2671dde1e58cad804f41648584</guid>
				<title>Sharpe posted an update: 0001); the median (IQR) MCCTT being 13.15 (10.24-17.25), [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28749/</link>
				<pubDate>Tue, 28 Jan 2025 11:41:47 -0800</pubDate>

									<content:encoded><![CDATA[<p>0001); the median (IQR) MCCTT being 13.15 (10.24-17.25), 7.26 (6.18-9.17), and 7.24 (5.73-8.73) minutes for current, former and never smokers, respectively. Comparison between current smokers and former smokers was significantly different (p less then 0.0001). There was no significant difference between former and never smokers. The Saccharin test&hellip;<span class="activity-read-more" id="activity-read-more-28749"><a href="http://www.nationalboardinstitute.com/activity/p/28749/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">414d88bf743b6cd14e120865a2878a12</guid>
				<title>Sharpe became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/28597/</link>
				<pubDate>Tue, 28 Jan 2025 11:32:08 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>